Search company, investor...

Regenesance

regenesance.com

Stage

Seed | Dead

About Regenesance

Regenesance is a specialty pharmaceutical company developing drugs to treat acute and chronic nerve disorders.

Headquarters Location

Meibergdreef 45 R-Noord 01-152

1105 BA,

Netherlands

Loading...

Loading...

Regenesance Patents

Regenesance has filed 8 patents.

The 3 most popular patent topics include:

  • complement system
  • clusters of differentiation
  • immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/1/2020

2/28/2023

Antibodies that bind human c6 and uses thereof

Complement system, Clusters of differentiation, Immune system, Monoclonal antibodies, Immunology

Grant

Application Date

5/1/2020

Grant Date

2/28/2023

Title

Antibodies that bind human c6 and uses thereof

Related Topics

Complement system, Clusters of differentiation, Immune system, Monoclonal antibodies, Immunology

Status

Grant

Regenesance Frequently Asked Questions (FAQ)

  • What is Regenesance's latest funding round?

    Regenesance's latest funding round is Seed.

  • Who are the investors of Regenesance?

    Investors of Regenesance include Life Sciences Fund Amsterdam.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.